Market OverviewAccording to MRFR's analysis, the amblyopia market will rise at a healthy CAGR of 4.20% through 2030, reaching a market value of USD 6.25 billion. The growing awareness about vision defects and eye health is likely to be one of the most important drivers of the global amblyopia market. The rising prevalence of nearsightedness and an increasing number of precautions taken to promote eye health are likely to drive the market for amblyopia over the forecast period. The improvement of the healthcare infrastructure in developed and emerging economies is likely to be one of the most important market drivers over the forecast period.Another major factor in this market is the emergence of new technologies and increasing investments in the segment by several private and public players. This provides a number of opportunities for the market to capitalize on.The increasing application of artificial intelligence in healthcare is likely to provide a stable platform for the on-going developments of the global amblyopia market. As the use of AI in major diagnoses and screening processes is on the rise, the potential of the amblyopia market is likely to increase significantly.The COVID-19 pandemic has been a major factor in the ongoing developments in the healthcare segment and continues to impact the amblyopia market considerably. In addition, the fact that the virus has led to an increase in sedentary lifestyles and screen time around the globe, which could potentially result in eye strain and refractive errors, is anticipated to stimulate the growth of the worldwide amblyopia market. The industry is projected to grow dramatically over the next few years due to the growing awareness of eye health and the ease of access to rapid medical care.
Major Companies Cover Analyzed in the Amblyopia Market Research Study:
- Generation Health, LLC
- Pfizer, Inc.
- Pixium Vision
- DigiSight
- Essilor International SA
- Novartis AG
- Allergan, Inc.
- Novartis Pharmaceuticals Corporation
- Omeros Corporation
- Alimera Sciences, Inc.
- AcuFocus, Inc.
- ReNeuron Group Plc
Market SegmentationMRFR’s report provides a segmental review of the global amblyopia market for a better understanding of the market. The market is segmented based on treatment, type, and region.By treatment, the amblyopia market is segmented into artificial intelligence, visual therapy, eye patch, and surgery. Of these, the visual therapy segment is likely to acquire the largest market share in the coming years, as this is the most efficient and economical option to treat amblyopia in humans.By type, the amblyopia market can be segmented into strabismic amblyopia, refractive amblyopia, and deprivational amblyopia. Of these, the refractive amblyopia segment has acquired the largest market share so far and is likely to remain the most important segment over the next few years.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Amblyopia Market Research Report
Regional Analysis
The study by MRFR examines the regional segmentation of the amblyopia market in in detail. The market is comprised of North America, Europe, Asia-Pacific, and Rest of The World (RoW) as its primary geographical segments.North America holds the largest market share for amblyopia and is likely to grow at an impressive rate in the coming years. The growing expenditure in the healthcare sector and the increasing prevalence of eye defects in the region, along with the number of treatments provided, are likely to boost the regional market.Europe comes in second in the global amblyopia market size, with the developments in the healthcare sector boosting the market significantly. The increasing prevalence of eye defects and the demand for advanced and efficient treatments are likely to drive the regional market.The Asia-Pacific market is a formidable competitor for the global amblyopia market share and is anticipated to expand at a rapid rate over the forecast period. This is attributable to the rising population in a number of countries in the region, as well as the growing awareness of eye health.Market ForecastMRFR’s report has offered an 8-year market forecast for the amblyopia market on the basis of the market performance in the last two years. This provides a clearer understanding of the current market trend and its likely future developments.Competitive AnalysisThe global amblyopia market is a highly competitive market with a number of players operating in it. Several manufacturers and research institutes are undertaking strategic activities to stay ahead of the competition. These players are focusing on activities such as product innovations, mergers and acquisitions, and strategic collaborations to remain at the forefront of amblyopia market.Generation Health, LLC, pfizer, Inc., Pixium Vision, DigiSight, Essilor International SA, Novartis AG, Allergan, Inc., Novartis Pharmaceuticals Corporation, Omeros Corporation, Alimera Sciences, Inc., AcuFocus, Inc., and ReNeuron Group Plc. are some of the major players operating in the global amblyopia market.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Report details
| Companies Covered | 15 |
| Pages | 108 |
Certified Global Research Member
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
